ESR1 gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ESR1
gene status correlates with estrogen receptor protein levels measured by ligand binding assay and immunohistochemistry
Authors
Keywords
-
Journal
Molecular Oncology
Volume 6, Issue 4, Pages 428-436
Publisher
Wiley
Online
2012-05-09
DOI
10.1016/j.molonc.2012.04.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry
- (2017) D. Craig Allred et al. Journal of the National Comprehensive Cancer Network
- ESR1 Amplification is Rare in Breast Cancer and is Associated with High Grade and High Proliferation: A Multiplex Ligation-Dependent Probe Amplification Study
- (2015) Cathy B. Moelans et al. Analytical Cellular Pathology
- Estrogen Receptor (ER) mRNA and ER-Related Gene Expression in Breast Cancers That Are 1% to 10% ER-Positive by Immunohistochemistry
- (2012) Takayuki Iwamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment
- (2011) S C Drury et al. ENDOCRINE-RELATED CANCER
- Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status
- (2011) Kirsten Vang Nielsen et al. Molecular Oncology
- ESR1 Is Co-Expressed with Closely Adjacent Uncharacterised Genes Spanning a Breast Cancer Susceptibility Locus at 6q25.1
- (2011) Anita K. Dunbier et al. PLoS Genetics
- Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancer
- (2010) Kirsten Vang Nielsen et al. BREAST CANCER RESEARCH AND TREATMENT
- Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
- (2010) Mahmoud R. Khoshnoud et al. BREAST CANCER RESEARCH AND TREATMENT
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer
- (2009) Katrine L. Henriksen et al. ACTA ONCOLOGICA
- Gene amplification in ductal carcinoma in situ of the breast
- (2009) L. Burkhardt et al. BREAST CANCER RESEARCH AND TREATMENT
- Estrogen receptor α geneESR1amplification may predict endocrine therapy responsiveness in breast cancer patients
- (2009) Saori Tomita et al. CANCER SCIENCE
- Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer
- (2009) Cathy B Moelans et al. MODERN PATHOLOGY
- Estrogen Receptor analyses in the Danish Breast Cancer Cooperative Group. History, methods, prognosis and clinical implications
- (2008) Maj-Lis M. Talman et al. ACTA ONCOLOGICA
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Anne Vincent-Salomon et al. NATURE GENETICS
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Jorge S Reis-Filho et al. NATURE GENETICS
- Conflicting evidence on the frequency of ESR1 amplification in breast cancer
- (2008) Donna G Albertson NATURE GENETICS
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Lindsay A Brown et al. NATURE GENETICS
- ESR1 gene amplification in breast cancer: a common phenomenon?
- (2008) Hugo M Horlings et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More